Dr. Agarwal's Health Care Limited has informed the Exchange about Transcript

Dr. Agarwal's Health Care reported Q1 FY26 total income of INR 501 crores, up 22.3% year-on-year, with revenue from operations rising 20.8% to INR 487 crores. Ind AS EBITDA grew 28.9% to INR 141 crores with margins improving 140 basis points to 28.2%, while profit after tax more than doubled to INR 38 crores, with PAT margin expanding 315 bps to 7.6%. The company served over 7 lakh patients and performed nearly 79,000 surgeries across 249 facilities, and added 13 new greenfield centres during the quarter, including a flagship tertiary facility in Delhi. Management guided to continued PAT margin expansion over the next 2-3 years and a 1-1.5% improvement in ROCE, while INR 195 crores of IPO proceeds have been used to repay debt, lowering finance costs. Plans are in place to open 42 more facilities in the remaining three quarters, and the proposed merger of the listed subsidiary with the holding company is targeted to be completed within 1-1.5 years.